Breakthroughs in Alzheimer's: Exploring New Medications and Behavioral Therapies
This session will highlight the latest advancements in Alzheimer’s treatment, including the recent FDA approval of Donanemab, a promising new drug.
This session will highlight the latest advancements in Alzheimer’s treatment, including the recent FDA approval of Donanemab, a promising new drug.